Skip Nav Destination
How I treat pediatric venous thromboembolism
A MALT lymphoma prognostic index
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Issue Archive
September 21 2017
Table of Contents
INSIDE BLOOD COMMENTARIES
BLOOD SPOTLIGHT
HOW I TREAT
How I treat pediatric venous thromboembolism
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
A MALT lymphoma prognostic index
CME
Clinical Trials & Observations
Catherine Thieblemont,Luciano Cascione,Annarita Conconi,Barbara Kiesewetter,Markus Raderer,Gianluca Gaidano,Maurizio Martelli,Daniele Laszlo,Bertrand Coiffier,Armando Lopez Guillermo,Valter Torri,Franco Cavalli,Peter W. Johnson,Emanuele Zucca
LYMPHOID NEOPLASIA
Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma
Maciej Szydłowski,Monika Prochorec-Sobieszek,Anna Szumera-Ciećkiewicz,Edyta Derezińska,Grażyna Hoser,Danuta Wasilewska,Olga Szymańska-Giemza,Ewa Jabłońska,Emilia Białopiotrowicz,Tomasz Sewastianik,Anna Polak,Wojciech Czardybon,Michał Gałęzowski,Renata Windak,Jan Maciej Zaucha,Krzysztof Warzocha,Krzysztof Brzózka,Przemysław Juszczyński
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)
Joonhee Park,Jingyi Yang,Alexander T. Wenzel,Akshaya Ramachandran,Wung J. Lee,Jay C. Daniels,Juhyun Kim,Estela Martinez-Escala,Nduka Amankulor,Barbara Pro,Joan Guitart,Marc L. Mendillo,Jeffrey N. Savas,Titus J. Boggon,Jaehyuk Choi
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function
Thati Madhusudhan,Hongjie Wang,Sanchita Ghosh,Wei Dong,Varun Kumar,Moh'd Mohanad Al-Dabet,Jayakumar Manoharan,Sumra Nazir,Ahmed Elwakiel,Fabian Bock,Shrey Kohli,Andi Marquardt,Ibrahim Sögüt,Khurrum Shahzad,Andreas J. Müller,Charles T. Esmon,Peter P. Nawroth,Jochen Reiser,Triantafyllos Chavakis,Wolfram Ruf,Berend Isermann
TRANSPLANTATION
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations
Charline Miot,Kohsuke Imai,Chihaya Imai,Anthony J. Mancini,Zeynep Yesim Kucuk,Tokomki Kawai,Ryuta Nishikomori,Etsuro Ito,Isabelle Pellier,Sophie Dupuis Girod,Jeremie Rosain,Shinya Sasaki,Shanmuganathan Chandrakasan,Jana Pachlopnik Schmid,Tsubasa Okano,Estelle Colin,Alberto Olaya-Vargas,Marco Yamazaki-Nakashimada,Waseem Qasim,Sara Espinosa Padilla,Andrea Jones,Alfons Krol,Nyree Cole,Stephen Jolles,Jack Bleesing,Thomas Vraetz,Andrew R. Gennery,Mario Abinun,Tayfun Güngör,Beatriz Costa-Carvalho,Antonio Condino-Neto,Paul Veys,Steven M. Holland,Gulbu Uzel,Despina Moshous,Benedicte Neven,Stéphane Blanche,Stephan Ehl,Rainer Döffinger,Smita Y. Patel,Anne Puel,Jacinta Bustamante,Erwin W. Gelfand,Jean-Laurent Casanova,Jordan S. Orange,Capucine Picard
LETTERS TO BLOOD
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Clinical Trials & Observations
Isabelle Krämer,Stephan Stilgenbauer,Sascha Dietrich,Sebastian Böttcher,Matthias Zeis,Michael Stadler,Jörg Bittenbring,Lutz Uharek,Christof Scheid,Ute Hegenbart,Anthony Ho,Michael Hallek,Michael Kneba,Norbert Schmitz,Hartmut Döhner,Peter Dreger
BLOOD WORK
ERRATUM
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
![issue cover]()
PIM kinases, expressed by classical Hodgkin lymphoma Reed-Sternberg (RS) cells, support tumor cell survival and facilitate its immune escape. The image shows the expression of PIM2 kinase (brown) in RS cells in a formalin-fixed, paraffin-embedded classical Hodgkin lymphoma diagnostic section. See the article by Szydłowski et al on page 1418.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement
